Eric Poma
Amministratore Delegato presso MOLECULAR TEMPLATES, INC.
Patrimonio netto: 21 283 $ in data 30/06/2024
Profilo
Eric E.
Poma is the founder of Molecular Templates, Inc. (founded in 2000) where he holds the title of Director, Chief Executive & Scientific Officer.
He is currently the Chief Executive Officer & Director at Molecular Templates OpCo, Inc. Dr. Poma previously worked at ImClone LLC as the Vice President-Business Development from 2001 to 2013, and at Innovive Pharmaceuticals, Inc. as the Secretary & Vice President-Business Development from 2009 to 2013.
Dr. Poma has an undergraduate and doctorate degree from The University of North Carolina at Charlotte, an MBA from The Leonard N Stern School of Business, and undergraduate and doctorate degrees from the University of North Carolina at Chapel Hill.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 08/04/2024 | 18 507 ( 0.28% ) | 21 283 $ | 30/06/2024 |
Posizioni attive di Eric Poma
| Società | Posizione | Inizio |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Amministratore Delegato | 01/01/2000 |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Amministratore Delegato | - |
Precedenti posizioni note di Eric Poma
| Società | Posizione | Fine |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Corporate Officer/Principal | - |
Formazione di Eric Poma
| The Leonard N Stern School of Business | Masters Business Admin |
| University of North Carolina at Chapel Hill | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
- Borsa valori
- Insiders
- Eric Poma
